BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 28606731)

  • 1. Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT).
    Weiner DE; Gaussoin SA; Nord J; Auchus AP; Chelune GJ; Chonchol M; Coker L; Haley WE; Killeen AA; Kimmel PL; Lerner AJ; Oparil S; Saklayen MG; Slinin YM; Wright CB; Williamson JD; Kurella Tamura M;
    Am J Kidney Dis; 2017 Sep; 70(3):357-367. PubMed ID: 28606731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus.
    Freedman BI; Sink KM; Hugenschmidt CE; Hughes TM; Williamson JD; Whitlow CT; Palmer ND; Miller ME; Lovato LC; Xu J; Smith SC; Launer LJ; Barzilay JI; Cohen RM; Sullivan MD; Bryan RN; Wagner BC; Bowden DW; Maldjian JA; Divers J;
    Am J Kidney Dis; 2017 Nov; 70(5):627-637. PubMed ID: 28648301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Bicarbonate Concentration and Cognitive Function in Hypertensive Adults.
    Dobre M; Gaussoin SA; Bates JT; Chonchol MB; Cohen DL; Hostetter TH; Raphael KL; Taylor AA; Lerner AJ; Wright JT; Rahman M;
    Clin J Am Soc Nephrol; 2018 Apr; 13(4):596-603. PubMed ID: 29567858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive Function.
    Murray AM; Bell EJ; Tupper DE; Davey CS; Pederson SL; Amiot EM; Miley KM; McPherson L; Heubner BM; Gilbertson DT; Foley RN; Drawz PE; Slinin Y; Rossom RC; Lakshminarayan K; Vemuri P; Jack CR; Knopman DS
    Am J Kidney Dis; 2016 Apr; 67(4):593-600. PubMed ID: 26744128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND.
    Murea M; Hsu FC; Cox AJ; Hugenschmidt CE; Xu J; Adams JN; Raffield LM; Whitlow CT; Maldjian JA; Bowden DW; Freedman BI
    Nephrol Dial Transplant; 2015 Aug; 30(8):1322-9. PubMed ID: 25722384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume.
    Freedman BI; Gadegbeku CA; Bryan RN; Palmer ND; Hicks PJ; Ma L; Rocco MV; Smith SC; Xu J; Whitlow CT; Wagner BC; Langefeld CD; Hawfield AT; Bates JT; Lerner AJ; Raj DS; Sadaghiani MS; Toto RD; Wright JT; Bowden DW; Williamson JD; Sink KM; Maldjian JA; Pajewski NM; Divers J
    Kidney Int; 2016 Aug; 90(2):440-449. PubMed ID: 27342958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure.
    Kurella Tamura M; Gaussoin S; Pajewski NM; Zaharchuk G; Freedman BI; Rapp SR; Auchus AP; Haley WE; Oparil S; Kendrick J; Roumie CL; Beddhu S; Cheung AK; Williamson JD; Detre JA; Dolui S; Bryan RN; Nasrallah IM;
    Am J Kidney Dis; 2022 May; 79(5):677-687.e1. PubMed ID: 34543687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Urine Biomarkers of Kidney Tubule Injury and Dysfunction With Frailty Index and Cognitive Function in Persons With CKD in SPRINT.
    Miller LM; Rifkin D; Lee AK; Kurella Tamura M; Pajewski NM; Weiner DE; Al-Rousan T; Shlipak M; Ix JH
    Am J Kidney Dis; 2021 Oct; 78(4):530-540.e1. PubMed ID: 33647393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial.
    Weiner DE; Park M; Tighiouart H; Joseph AA; Carpenter MA; Goyal N; House AA; Hsu CY; Ix JH; Jacques PF; Kew CE; Kim SJ; Kusek JW; Pesavento TE; Pfeffer MA; Smith SR; Weir MR; Levey AS; Bostom AG
    Am J Kidney Dis; 2019 Jan; 73(1):51-61. PubMed ID: 30037726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders.
    Weiner DE; Bartolomei K; Scott T; Price LL; Griffith JL; Rosenberg I; Levey AS; Folstein MF; Sarnak MJ
    Am J Kidney Dis; 2009 Mar; 53(3):438-47. PubMed ID: 19070412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated GFR, Albuminuria, and Cognitive Performance: The Maastricht Study.
    Martens RJ; Kooman JP; Stehouwer CD; Dagnelie PC; van der Kallen CJ; Koster A; Kroon AA; Leunissen KM; Nijpels G; van der Sande FM; Schaper NC; Sep SJ; van Boxtel MP; Schram MT; Henry RM
    Am J Kidney Dis; 2017 Feb; 69(2):179-191. PubMed ID: 27291486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations Between Kidney Disease Measures and Regional Pulse Wave Velocity in a Large Community-Based Cohort: The Atherosclerosis Risk in Communities (ARIC) Study.
    Kim ED; Tanaka H; Ballew SH; Sang Y; Heiss G; Coresh J; Matsushita K
    Am J Kidney Dis; 2018 Nov; 72(5):682-690. PubMed ID: 30007506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Kidney Function Biomarkers with Brain MRI Findings: The BRINK Study.
    Vemuri P; Knopman DS; Jack CR; Lundt ES; Weigand SD; Zuk SM; Thostenson KB; Reid RI; Kantarci K; Slinin Y; Lakshminarayan K; Davey CS; Murray A
    J Alzheimers Dis; 2017; 55(3):1069-1082. PubMed ID: 27767995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults.
    Tamura MK; Pajewski NM; Bryan RN; Weiner DE; Diamond M; Van Buren P; Taylor A; Beddhu S; Rosendorff C; Jahanian H; Zaharchuk G;
    Neurology; 2016 Mar; 86(13):1208-16. PubMed ID: 26920359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of Chronic Kidney Disease Markers with Cognitive Function: A 12-Year Follow-Up Study.
    Sacre JW; Magliano DJ; Zimmet PZ; Polkinghorne KR; Chadban SJ; Anstey KJ; Shaw JE
    J Alzheimers Dis; 2019; 70(s1):S19-S30. PubMed ID: 30372677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain Magnetic Resonance Imaging Findings in Children and Young Adults With CKD.
    Hartung EA; Erus G; Jawad AF; Laney N; Doshi JJ; Hooper SR; Radcliffe J; Davatzikos C; Furth SL
    Am J Kidney Dis; 2018 Sep; 72(3):349-359. PubMed ID: 29398180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.
    Malhotra R; Craven T; Ambrosius WT; Killeen AA; Haley WE; Cheung AK; Chonchol M; Sarnak M; Parikh CR; Shlipak MG; Ix JH;
    Am J Kidney Dis; 2019 Jan; 73(1):21-30. PubMed ID: 30291012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Albuminuria With White Matter Hyperintensities Volume on Brain Magnetic Resonance Imaging in Elderly Japanese - The Hisayama Study.
    Yamasaki K; Hata J; Furuta Y; Hirabayashi N; Ohara T; Yoshida D; Hirakawa Y; Nakano T; Kitazono T; Ninomiya T
    Circ J; 2020 May; 84(6):935-942. PubMed ID: 32269184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Kidney Function Measures With Signs of Neurodegeneration and Small Vessel Disease on Brain Magnetic Resonance Imaging: The Atherosclerosis Risk in Communities (ARIC) Study.
    Scheppach JB; Wu A; Gottesman RF; Mosley TH; Arsiwala-Scheppach LT; Knopman DS; Grams ME; Sharrett AR; Coresh J; Koton S
    Am J Kidney Dis; 2023 Mar; 81(3):261-269.e1. PubMed ID: 36179945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial.
    Rapp SR; Gaussoin SA; Sachs BC; Chelune G; Supiano MA; Lerner AJ; Wadley VG; Wilson VM; Fine LJ; Whittle JC; Auchus AP; Beddhu S; Berlowitz DR; Bress AP; Johnson KC; Krousel-Wood M; Martindale-Adams J; Miller EC; Rifkin DE; Snyder JK; Tamariz L; Wolfgram DF; Cleveland ML; Yang M; Nichols LO; Bryan RN; Reboussin DM; Williamson JD; Pajewski NM;
    Lancet Neurol; 2020 Nov; 19(11):899-907. PubMed ID: 33098800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.